Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies, DKFZ to Create High-Throughput Sequencing Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies and the German Cancer Research Center (Deutsches Krebsforschungszentrum, or DKFZ) have formed an exclusive partnership to create the National High-Throughput Sequencing Center in Germany.

The partners said in a statement released after the close of the market Wednesday that the new center will be the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.

The center will use 10 of Life Technologies' SOLiD 4 hq systems, which have been acquired by DKFZ. Researchers at the new center plan to initially sequence 1,000 whole human cancer genomes for Germany's national contribution to the International Cancer Genome Consortium.

"This center will be the first facility that will systematically bring high-throughput sequencing technologically into systems biology applications on a large scale," Life Technologies President and COO Mark Stevenson said in a statement.

The facility will be partly funded by the German Federal Ministry of Education and Research. Further financial and other terms of the collaboration were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.